Demographic characteristics of the study population
| 4% Cromolyn cream | Placebo cream | p Value | |
|---|---|---|---|
| Median age (years) | 26 (24–45) | 27 (25–49) | 0.6 |
| Nulliparous | 11/13 (85%) | 10/13 (77%) | 1.0 |
| Median duration of symptoms (years) | 2.3 (1.5–3) | 2.0 (1.5–5) | 0.6 |
| Sexually active | 10/13 (77%) | 11/13 (85%) | 0.7 |
| History of recurrent candidiasis | 8/13 (62%) | 8/13 (62%) | 1.0 |
| Fluconazole maintenance | 7/13 (54%) | 5/13 (39%) | 0.4 |
| Previous therapies: | |||
| Corticosteroid ointment | 10/13 (77%) | 10/13 (77%) | 1.0 |
| Amitriptyline | 9/13 (69%) | 4/13 (31%) | 0.05 |
| Oestrogen cream | 2/13 (15%) | 3/13 (23%) | 1.0 |